|
|
Volumn 326, Issue 7397, 2003, Pages 1004-
|
|
FDA announces fast track approval of new drug for lung cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
GENERIC DRUG;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LUNG TUMOR;
UNITED STATES;
ADVERTIZING;
DENMARK;
DRUG INDUSTRY;
MEDICAL ETHICS;
PRACTICE GUIDELINE;
STANDARD;
UNITED KINGDOM;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
HUMANS;
LUNG NEOPLASMS;
QUINAZOLINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
ADVERTISING;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CITALOPRAM;
CODES OF ETHICS;
DENMARK;
DRUG INDUSTRY;
DRUGS, GENERIC;
GREAT BRITAIN;
GUIDELINES;
MLCS;
MLOWN;
|
|
EID: 0038011975
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.326.7397.1004/d Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
